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Abstract
Transforming growth factor alpha
(TGF a) is a polypeptide, which binds to
the epidermal growth factor receptor to
carry out its function related to cell
proliferation and differentiation. The
ultrastructural localisation of TGF a was
studied in both the proximal and the distal
colon. The columnar cells, lining the
surface epithelium of the proximal colon,
showed a strong immunoreactivity in the
polyribosomes and in the interdigitations
of the lateral membrane. The columnar
cells of the crypts and the goblet cells in
both the proximal and the distal colon
showed the immunostaining in the cis and
trans cisternae of the Golgi apparatus.
TGF a seems to be processed differently in
the surface columnar cells and in the crypt
columnar cells and goblet cells. Moreover,
it probably has different roles in prolifera-
tion and differentiation.
(Gut 1994; 35: 1086-1089)
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Transforming growth factor alpha (TGF at) is
a 50 amino acid polypeptide structurally
and functionally related to epidermal growth
factor, which binds to the epidermal
growth factor/TGF a receptor.' TGF ao was
originally isolated from retrovirally transformed
3T3 cells2 and has also been shown to be
expressed by chemically transformed cells.34
TGF at is synthesised as a larger precursor of
159 or 160 amino acids, which is an integral
membrane glycoprotein (pro TGF a). The
mature form is released by proteolytic cleavage
of pro TGF a.5 6 Different forms of pro
TGF a have been shown to accumulate in the
membranes of growth factor producing cell
lines. Solubilised precursors induce tyrosine
autophosphorylation of the epidermal growth
factor/TGF a receptor in intact receptor over-
expressing cells, and anchorage independent
growth of NRK fibroblasts.7 This membrane
anchored growth factor precursor may have
an important role in developmental processes
that require cell-cell interactions that are
not compatible with the diffusible nature of
secretory factors. TGF a mRNA and protein
has been described during embryonic develop-
ment8 9 and in several adult tissues including
pituitary,'0 brain,"1 macrophages,'2 skin kera-
tinocytes,13 kidney,'4 and colon.15
Up to now, a morphological study of the
subcellular localisation of TGF at and its
secretion has been lacking. To consider
this issue, we studied the ultrastructural
distribution of TGF a protein in normal rat
colon, based on our previous study at the
light microscopy level.'5 Our results support
a possible role for TGF ao in the modulation
of proliferation and differentiation of the
intestinal epithelium.
Methods
TISSUES
Adult Sprague Dawley rats weighing 150-320 g
were killed by cervical dislocation. The
abdominal wall was opened and the proximal
and distal colon were dissected out intact.
IMMUNOELECTRON MICROSCOPY
Small pieces of proximal and distal colon were
fixed in a mixture of2% paraformaldehyde and
1% glutaraldehyde in phosphate buffered
saline (PBS) for two hours at 4°C. After
washing in PBS the specimens were incubated
in 50 mM NH4Cl in PBS for 60 minutes
to block aldehyde residues. The specimens
were dehydrated in a graded ethanol series
and embedded in Lowicryl K4M. Ultrathin
sections were cut on a Reichert-Imy ultracut
ultramicrotome using a diamond knife, and
mounted on a nickel grid coated with formvar
and carbon.
Labelling of the immunoreactive sites was
achieved by indirect on grid immunogold
staining as previously described.16 The
sections were incubated on a drop of normal
goat serum (diluted 1:30 in PBS pH 7 2, 0 1/o%
bovine albumin, 0-01% sodium azide (NaAz))
for 30 minutes to block the background and for
two hours at room temperature in mouse
monoclonal anti-TGF a ((diluted 2 ,ug/ml) in
PBS-bovine serum albumin-NaAz; Oncogene
Science, ref GF10). The anti-TGF at antibody
recognises a human TGF ao epitope (residues
34-50) and it does not crossreact with epi-
dermal growth factor. 17 The sections were
washed on five drops of PBS and the primary
antibodies were localised using colloidal gold
(10 nm diameter) labelled goat antimouse
IgG (diluted 1:60 in PBS-bovine serum
albumin-0 05% Tween 20; Sigma, ref G2272)
for one hour at room temperature. The
sections were washed on drops of PBS and
distilled water and stained with 2% uranyl
acetate and lead citrate. Electron micrographs
were taken using a Philips 301 electron
microscope.
NEGATIVE CONTROL
The following were included as negative
controls: (a) primary incubation with PBS-
bovine serum albumin-NaAz, (b) primary
1086
 group.bmj.com on April 18, 2011 - Published by gut.bmj.comDownloaded from 
Immunoelectron microscopic localisation of transforming growth factor alpha in rat colon
.
.:~.. J,
- ;.z
y.,. ..44
Figure 3: Electron micrograph ofsurface columnar cell
(CC) in the proximal colon. TGF a immunoreactivity is
localised with 10 nm gold particles in the interdigitations of
the lateral membranes and in the polyribosomes. No
immunoreactivity was seen in the neighbouring goblet cell
(GC). Mitochondria (M), interdigitations (arrowhead),
and rough endoplasmic reticulum (rER) are shown.
(Immunogold test; bar represents 0 35 ,um.)
Figure 1: Electron micrograph ofsurface columnar cell in
the proximal colon. An intense labelling with 10 nm gold
particles is seen distributed throughout the cytoplasm.
Mitochondria (M), microviUi (arrowhead), and clear
vesicle (asterisk) are shown. (Immunogold test; bar
represents 0-35 ,um.)
incubation with anti-TGF a (2 ,ug/ml) pre-
absorbed with rat TGF a (30 pug/ml, fragment
1-50, Bachem, ref H-5545) for 24 hours
at 40C.
Results
The proximal and the distal colon, lined by
columnar cells, showed abundant microvilli
projecting from the apical plasma membrane.
Membrane bound vesicles were commonly seen
Figure 2: Electron micrograph ofsurface columnar cell in
the proximal colon. TGF a immunoreactivity is associated
with the polyribosomes. Note that the rough endoplasmic
reticulum (rER) did not show any staining. (Immunogold
test; bar represents 0 35 mm.)
in the web region. A Golgi complex, small clear
vesicles, and abundant mitochondria were seen
in the supranuclear region. Both smooth and
rough endoplasmic reticulum could also be seen
through the cytoplasm. The nucleus was
located in the basal third of the cell.
Positive staining with the anti-TGF a
antibody was seen in the columnar cells of
the proximal colon and the strongest reaction
confined to the cytoplasm (Fig 1), was regularly
associated with polyribosomes (Fig 2). Nuclei,
mitocondria, smooth and rough endoplasmic
reticulum, and small clear vesicles did not
show any immunoreactivity. Positive immuno-
reactivity was also identified in the interdigita-
tions of the lateral membranes (Fig 3).
Furthermore, hardly any immunoreactivity was
seen on the microvilli of the columnar cells.
In the proximal colon, the crypts are
longer than in other parts of the colon. The
upper two thirds are lined by columnar and
goblet cells. The lower part is covered by goblet
cells. The distal colon has shorter crypts. The
upper part is lined by columnar and goblet cells.
The lower part is mainly covered by goblet cells
and a smaller number of columnar cells.
The columnar cells of the crypts in both the
proximal and the distal colon showed positive
staining with the anti-TGF a antibody in the
cisternae of the Golgi apparatus (Fig 4). We
could not find any immunoreactivity in the
cytoplasm.
In both the proximal and the distal colon,
the goblet cells are characterised by mucous
granules occupying the apical two thirds of
the cell. The nucleus is located in the basal
Figure 4: Electron micrograph of crypt columnar cell in the
distal colon. TGF a antibody shows an intense labelling in
the cisternae membranes of the Golgi apparatus (G).
(Immunogold test; bar represents 0 35 Am.)
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Figure 5: Electron micrograph of crypt goblet cell of
proximal colon. Immunoreaction for TGF a is seen in the
cisternae and the secretory vesicles (SV) of the Golgi
apparatus (G). Rough endoplasmic reticulum (rER).
(Immunogold test; bar represents 0-035 ,um.)
region of the cell and a Golgi complex is
usually seen in the supranuclear region.
The immunoreactivity was mainly located
in the Golgi apparatus of both cis and trans
cisternaes. The gold particles were confined to
the cisternae membranes (Figs 5 and 6). The
mucous granules were also heavily labelled
with gold particles (Fig 7).
Discussion
The intestinal epithelium is a very dynamic
tissue, in which cells migrate distally along
the crypt-villus axis and the capacity for pro-
liferation is lost. Sophisticated, differentiated,
absortive, and digestive functions are pro-
gressively acquired. TGF at may have a role
in colonic mucosal proliferation and differen-
tiation. We report here, for the first time, the
ultrastructural identification of TGF a in the
proximal and distal rat colon.
TGF a mRNA in CHO cells (Chinese
hamster ovary fibroblast) is processed in the
rough endoplasmic reticulum and Golgi
apparatus, and anchored to the plasmatic
membrane.'8 We found, however, the specific
immunostaining in the polyribosomes of the
surface columnar cells of the proximal colon.
This localisation could suggest that the coding
sequence of the TGF ao mRNA has been
processed by alternate splicing of the gene
in the surface columnar cells. The alternate
splicing of the TGF a mRNA has been
reported before in the brain.19 Some cell lines
such as A375, FeSV/FRE,16 and SW620
(colon adenocarcinoma) showed a high syn-
thesis ofTGF ot20 and displayed a cytoplasmic
staining, as we described in surface columnar
cells. On the other hand, columnar cells in
both proximal and distal crypts presented
TGF a staining in the cisternae of the Golgi
apparatus as described by Teixido et al18 in
CHO cells. Furthermore, the apical membrane
of both surface and crypt columnar cells did
not show gold particles label suggesting that
the TGF a precursor is not anchored in the
apical membrane in those cell types. This find-
ing may be supported by the experiments
of Choudry et al 21 and Barnes et al .22 They
identified an endopeptidase-2 in the intestinal
brush border, which hydrolysed the TGF ao
(this enzyme degraded about 30 nmol of
h=TGF a/h per mg of protein), and this may
explain the absence of staining in the luminal
Figure 6: Electron micrograph of crypt goblet cell of distal
colon. Note that the cisternae (C) of the Golgi apparatus
were swollen with a hypotonic buffer to clarify that the
labelling is mainly located in the cisternae membranes and
not in the lumen of the cisternae. Rough endoplasmic
reticulum (rER). (Immunogold test; bar represents
0-35 Am.)
surface. We also found, however, some label
associated with the interdigitations of the
lateral membrane in the surface and crypt
columnar cells. In this case, TGF aL could be
functioning as a type of receptor or interacting
with the epidermal growth factor/TGF a
receptor on a neighbouring cell, having a
role that requires discrete cell-cell interactions,
not compatible with release of the soluble
factor. Many studies have been performed
on the presence of epidermal growth
factor/TGF a receptor in colon epithelium in
the adult rodent.24 Thus, the influence of
TGF aL in the colonic mucosa may regulate
the balance between proliferation and differen-
tiation by means of binding to epidermal
growth factor/TGF a receptor.25
Goblet cells in the proximal and distal colon
showed the immunoreactivity located in the
Golgi apparatus and in the mucous granules.
This suggests TGF ot must be secreted by
goblet cells and also bind to epidermal growth
N!*t ^ e ;. ; .+ ; > .77 ., ,,
Figure 7: Electron micrograph of crypt goblet cell of distal
colon. Immunostaining for TGF a is localised to the
membranes of the cisternae and the mucous granules (g)
of the Golgi apparatus G). Rough endoplasmic reticulum
(rER). (Immunogold test; bar represents 035 mm.)
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factor/TGF ct receptor, present in colon
epithelium, to induce its biological effects. A
recent study reported the association of epider-
mal growth factor with other proteins in high
molecular weight complexes in human milk.26
Like epidermal growth factor, TGF (x secreted
in the mucous granules of the goblet cells
could be associated with other glycoproteins to
prevent its hydrolysation by endopeptidase 2.
Therefore, columnar and goblet cells may
make distinctive and unequal contributions to
overall epithelial production ofTGF a.
The colonic epithelium is a rapidly prolifer-
ating organ that completely renews itself on a
weekly basis.27 On the other hand, neoplasia of
the normal colonic epithelium goes through
ordered stages, first to adenomatous then to
malignant change. Epidermal growth factor/
TGF ax receptor and TGF ot production have
been individually detected in colon carcinomas
and in numerous colon cancer cell lines.28 29
Coexpression ofTGF ot and epidermal growth
factor receptor and growth stimulation by
TGF ox has also been shown in multiple colon
cancer cell lines, and TGF ot has been pro-
posed as an autocrine growth factor in colon
cancer. Processing of pro TGF ot in neoplastic
cells is generally inefficient and many cell types
also secrete large forms of TGF cx in varying
proportions.30 Some of these larger species
correspond to the extracellular domain of
pro TGF cx, which has been heterogeneously
glycosilated through the addition of both
N and 0 linked carbohydrate.31 33
In this study we provide evidence of TGF ac
presence in normal rat colon. Its different sub-
cellular distribution, depending on the type of
cell, could be explained by distinct processing
pathways, somewhat similar to those found in
neoplastic cells.
In summary, we report here for the first
time, the identification of TGF cx at ultra-
structural level in normal rat colon, where it
did not act as a transforming factor. The
subcellular localisation ofTGF cx in neoplastic
tissues and its comparison with the distribution
in normal tissues need to be considered to
identify distinct secretion mechanisms of TGF
cx and therefore its different effects in prolifera-
tion and differentiation.
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